They find how to set the ideal dose of lithium for bipolar disorder
The ideal amount of lithium to treat a patient with bipolar disorder can be determined by six predictive factors, which will help reduce episodes of depression and mania, minimizing side effects.
...
Combining these drugs with ibuprofen can damage your kidneys
Patients with hypertension usually follow a treatment based on diuretics and renin-angiotensin system inhibitors, a study reveals that mixing these drugs with ibuprofen could permanently damage the kidneys.
...
First specific drug for chronic insomnia approved in Europe
Quviviq® (Daridorexant) is the first drug specifically designed to treat chronic insomnia approved by the European Commission, it works by decreasing the trigger for wakefulness to allow the patient to fall...
They create a vaccine against the Epstein-Barr virus, which causes sclerosis
An experimental vaccine prevents infection by Epstein-Barr (EBV), a virus that causes kissing sickness and has been linked to multiple sclerosis and certain cancers, a study in mice, ferrets and macaques...
Vydura, first drug to treat and prevent migraine approved in the EU
Vydura is the first drug approved in the European Union to treat the symptoms of migraine in adults and that taken preventively by patients who suffer four or more attacks per...
Vigo scientists confirm that lithium is effective against COVID
Patients with COVID-19 admitted to the hospital could improve their immune response, in addition to preventing and reducing inflammation, thanks to lithium carbonate, a drug used in some psychiatric conditions.
...
They find the first antibody that attacks cancer and prevents metastasis
They discover MCLA-158, the first drug candidate antibody directed at cancer stem cells in solid tumors that slows the growth of tumors and blocks metastasis, without affecting healthy cells in the...
An asthma drug blocks a key coronavirus protein
Montelukast, a drug used to treat asthma, can bind to a protein –Nsp1– of SARS-CoV-2 that this virus needs to replicate in human cells, and block it, reducing the damage caused...
The 3rd dose of Pfizer loses efficacy after 3 months compared to ómicron
Booster doses of Pfizer's COVID-19 vaccine provide up to 90% protection against hospitalizations in the first few months, but a study now indicates that protection declines after the third month.
...
Strawberry-flavored pills make it easier to control HIV in children
Hospital 12 de Octubre demonstrates the safety and efficacy of dolutegravir, a soluble strawberry-flavored pill, to treat HIV infection in infants and children from three kilos and four weeks of age...
Meningitis B vaccines could protect against gonorrhea
Administering the meningococcal B vaccine can reduce the risk of contracting gonorrhea, a sexually transmitted infection, in young men and men who have sex with men by up to 40%, according...
Triple therapy improves survival in metastatic prostate cancer
Combining the drugs abiraterone, prednisone and docetaxel (chemotherapy) revolutionizes the treatment of metastatic prostate cancer by reducing the risk of disease progression by 50% and increasing survival up to 60 months.
...
An Austrian vaccine would protect against omicron and the rest of the variants
Austrian researchers have developed a vaccine that, according to the first preclinical data obtained, could be effective against all variants of the SARS-CoV-2 virus, which causes COVID-19, including omicron.
...
The EMA does not yet advise getting a fourth dose of the COVID vaccine
The European Medicines Agency concludes that it is still too early for a second booster dose against COVID-19 – which would be the fourth injection for many – although it does...
Molnupiravir eliminates SARS-CoV-2 on the third day of starting to take it
A Merck study demonstrates the efficacy of its antiviral molnupiravir in eliminating actively infectious SARS-CoV-2, as it is capable of killing the virus in infected patients three days after starting therapy.
...
Weekly prednisone, possible future option to treat obesity
Scientists at Northwestern University have found that administering prednisone once a week to obese mice managed to improve their resistance to exercise, and increased their body mass while losing fat and...
Gene therapy cures non-healing wounds in ‘butterfly children’
A topically applied gel developed using gene therapy heals wounds in nine patients with 'butterfly skin', which had not healed for years and remained closed for months after treatment.
...
The EMA evaluates the Spanish Hipra vaccine as a booster against COVID
The European Medicines Agency (EMA) announces that it has begun the evaluation of the Spanish HIPRA vaccine against COVID-19 for its approval, which if approved, could be included in the group...
A drug stops 75% of cases of metastatic breast cancer
A drug that enters tumor cells without being detected and destroys them is capable of stopping metastatic HER2-positive breast cancer in 75.8% of patients, according to a clinical trial.
...
Antibiotics in middle-aged women linked to cognitive decline
Middle-aged women who take antibiotics for long periods of time may be at higher risk of developing cognitive impairment that affects their speed of thinking, attention, learning and memory.
...
Nausea drugs may increase stroke risk
Antidopaminergic antiemetics such as domperidone, drugs intended to combat nausea and vomiting, could be linked to an increased risk of stroke or ischemic cerebrovascular accident, especially in the first days of...
Green light to the antiviral anti-COVID Evusheld for over 12 years
The European Medicines Agency (EMA) recommends the marketing authorization of the drug Evusheld, from AstraZeneca, to prevent COVID-19 in people over 12 years of age before possible exposure to the coronavirus.
...
Statins for cholesterol do not prevent cardiovascular pathology
Reducing 'bad' cholesterol (LDL) levels by taking statins has "modest" benefits when it comes to preventing the development of cardiovascular diseases such as heart attack or stroke, according to a new...
A fourth dose offers only marginal benefit over omicron
After Pfizer has said that it believes a fourth dose of its COVID-19 vaccine will be necessary, an Israeli study shows that the effects of a fourth injection would have only...
They create a drug to combat obesity and heart disease
American researchers develop a new drug that inactivates the enzyme related to cholesterol absorption and obesity, which shows promise for preventing metabolic disorders.
Obesity is...
The Pfizer vaccine appears less effective in children aged 5 to 11 years
The protection of the Pfizer-BioNTech vaccine against COVID-19 fell dramatically a month after the full course in children 5 to 11 years old during the January wave in New York. ...
Europe approves Moderna’s vaccine in children aged 6 to 11
The European Medicines Agency has recommended the administration of the Moderna COVID-19 vaccine for children between 6 and 11 years of age, in addition to advising the booster dose with Pfizer...
Omomyc is effective in stopping metastasis in breast cancer
Omomyc is a drug capable of fighting primary tumors and reducing their size. Vall d'Hebron now also demonstrates its efficacy in preventing the development of metastases in triple-negative breast cancer, in...
Moderna could launch an annual vaccine against COVID-19 and flu in 2023
The CEO of the Modern pharmaceutical company has announced that they are working on the development of a single-dose vaccine against COVID-19 and the flu, which would be given every year...
The 4th dose does not seem to protect well enough against omicron
Israel was the first country to administer the fourth dose of the COVID vaccine, a national study indicates that it increases antibodies, but does not seem to protect enough to prevent...
